Prostate Cancer: Shifting from Morphology to Biology

  • Stefania Staibano

Table of contents

  1. Front Matter
    Pages i-xviii
  2. Clues to Morphological Diagnosis and Prognosis Evaluation

  3. Molecular Pathology

    1. Front Matter
      Pages 43-43
    2. Francesco Merolla
      Pages 57-77
    3. Simona Romano, Rita Bisogni, Maria Fiammetta Romano
      Pages 79-86
    4. Renato Franco, Paolo Chieffi, Sisto Perdonà, Gaetano Facchini, Michele Caraglia
      Pages 87-109
    5. Stefania Staibano
      Pages 111-125
    6. Stefania Staibano
      Pages 127-142
    7. Stefania Staibano
      Pages 143-157
  4. Genetic and Epigenetic Events in Prostate Cancer

    1. Front Matter
      Pages 159-159
    2. Maria Siano, MariaLuisa Vecchione, Gennaro Ilardi
      Pages 161-182
    3. Stefania Staibano, Angela Celetti
      Pages 183-193
    4. Maria Siano, Silvia Varricchio, Gennaro Ilardi
      Pages 195-200
  5. A Modern Approach to Therapy of Prostate Cancer: Targeting the Deadly Subset

    1. Front Matter
      Pages 211-211
    2. Stefania Staibano, Paolo Antonio Ascierto
      Pages 221-231
    3. Ester Simeone, Antonio Maria Grimaldi, Paolo Antonio Ascierto, Francesco Merolla, Gennaro Ilardi, Maria Siano et al.
      Pages 247-254
  6. Back Matter
    Pages 289-296

About this book


The aim of this book will be to contribute to the education of a new generation of experts in urology, molecular biology, pathology and oncology, offering them sufficient knowledge in basic and translational research to be fluency in the web of interacting networks playing a role in prostate cancer development, progression, metastasis and drug-resistance.The volume will cover the latest innovative researches in prostate cancer, with particular emphasis to the state-of-the-art analysis technologies that are essential for the accurate identification of molecular targets for disease diagnosis, molecular mechanisms of tumorigenesis, markers for susceptibility, molecular-based prognostic prevision, characterization of biomarkers of drug efficacy and drug resistance, validation of new therapeutics and diagnostics. Current advancements on the intersecting data concerning transcriptomes, proteomes, and the molecular techniques referred as "omes”, will be reported and discussed.


biological behavior molecular pathways prognostic markers prostate cancer target therapy

Editors and affiliations

  • Stefania Staibano
    • 1
  1. 1.Biomedical Advanced Sciences Pathology SectionUniversity Federico II of NaplesNaplesItaly

Bibliographic information